Cargando…

Genomic predictors for treatment of late stage prostate cancer

In spite of the development of new treatments for late stage prostate cancer, significant challenges persist to match individuals with effective targeted therapies. Genomic classification using high-throughput sequencing technologies has the potential to achieve this goal and make precision medicine...

Descripción completa

Detalles Bibliográficos
Autor principal: Shevrin, Daniel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955183/
https://www.ncbi.nlm.nih.gov/pubmed/27030083
http://dx.doi.org/10.4103/1008-682X.177121